Your browser doesn't support javascript.
loading
Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial.
Roth, Thomas; Dauvilliers, Yves; Thorpy, Michael J; Kushida, Clete; Corser, Bruce C; Bogan, Richard; Rosenberg, Russell; Dubow, Jordan; Seiden, David.
Afiliación
  • Roth T; Henry Ford Hospital, Detroit, MI, USA.
  • Dauvilliers Y; National Reference Centre for Orphan Diseases, Narcolepsy, Rare Hypersomnia, Sleep Unit, Department of Neurology, CHU Montpellier, Institute for Neuroscience of Montpellier INM, University of Montpellier, INSERM, Montpellier, France.
  • Thorpy MJ; Albert Einstein College of Medicine, Bronx, NY, USA.
  • Kushida C; Stanford Sleep Medicine Center, Redwood City, CA, USA.
  • Corser BC; Sleep Management Institute, Cincinnati, OH, USA.
  • Bogan R; University of South Carolina School of Medicine, Columbia, SC, USA.
  • Rosenberg R; Neurotrials Research, Atlanta, GA, USA.
  • Dubow J; Clinical Development and Medical Affairs, Avadel Pharmaceuticals, 16640 Chesterfield Grove Road, Suite 200, Chesterfield, MO, 63005, USA.
  • Seiden D; Clinical Development and Medical Affairs, Avadel Pharmaceuticals, 16640 Chesterfield Grove Road, Suite 200, Chesterfield, MO, 63005, USA. Dseiden@avadel.com.
CNS Drugs ; 36(4): 377-387, 2022 04.
Article en En | MEDLINE | ID: mdl-35380374
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oxibato de Sodio / Narcolepsia Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: CNS Drugs Asunto de la revista: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oxibato de Sodio / Narcolepsia Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: CNS Drugs Asunto de la revista: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos